Chicken pox vaccine promises protection, cost savings

Article Abstract:

A newly approved vaccine against chickenpox called Varivax is likely to be widely used by pediatricians. Manufactured by Merck and Co, it will be available in May 1995 at a price of $39 per dose. Although most parents view chickenpox as just an inescapable childhood illness, a recent report by the Center for Disease Control shows that chickenpox also carries direct and indirect costs of approximately $384 million annually. The American Academy of Pediatrics is drawing up guidelines for the vaccine's use, and it is expected to be incorporated into recommended vaccination schedules almost immediately.

Biological products exc. diagnostic, Vaccines for Human Use, Planning, Usage, Prevention, Children, Vaccination of children, Vaccination, Vaccines, Viral vaccines, Chickenpox, Varivax (Vaccine)

---

Rising hopes, rising costs

Article Abstract:

Advances in HIV and AIDS treatment are being impeded by rising costs. Medicaid and state AIDS Drug Assistance Programs (ADAP) pay for 50% to 75% of prescriptions for antiretrovirals such as protease inhibitors. Enrollment in ADAPs has skyrocketed from 50,000 nationwide in 1994 to about 70,000 in 1995. However, many are hopeful that the need for increased funding will increase access to new drugs.

Health Care, Health Care and Social Assistance, HEALTH SERVICES, Finance, Medical care, HIV infection, Drug therapy, HIV infections, AIDS patients, AIDS (Disease), Drug therapy, Combination, Combination drug therapy

---

Doctors asked to be more aggressive in herpes screening

Article Abstract:

The American Social Health Assn is recommending that physicians become more vigilant in screening their patients for genital herpes. One in five Americans over 12 years old has the disease, which can spread to other organs and become life-threatening. Physicians are advised to obtain patients' sexual histories to assess risk factors and increase testing.

Research and Development in the Physical, Engineering, and Life Sciences, Research and Testing Services, Sexually Transmitted Disease R&D, Sexually transmitted diseases, Diagnosis, Herpes genitalis, Genital herpes, Disease reporting, Sexually transmitted disease research

Similar abstracts:

• Abstracts: The influence of physician gender on practice satisfaction among obstetrician gynecologists. Heavier workload, less personal control: impact of delivery on obstetrician/gynecologists' career satisfaction
• Abstracts: Malignancies, prothrombotic mutations, and the risk of venous thrombosis. Antiangiogenic therapy a two-trick pony?
• Abstracts: Debate Revived on Hepatitis B Vaccine Value. Therapies aim to boost "good" cholesterol
• Abstracts: Predicting future functional status for seriously ill hospitalized adults. Factors associated with do-not-resuscitate orders: patients' preferences, prognoses, and physicians' judgments
• Abstracts: AMA has remedy for malaise of physicians. AMA president: expand choice, save health system. A physician delivers on medical liability reform

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.